|
|
|
|
Could lowering blood pressure help stop dementia?
This coming fall, the U.S.National Institutes of Health will start enrolling participants in the largest trial thus far to see if lowering blood pressure can reduce reducethe risk of cognitive decline. iStockphoto.com/Lisa F. Young Alzheimers News...
|
|
|
Online, phone tests assess diabetes risk
WEDNESDAY, March 17 (HealthDay News) -- About 20 percent of Americans have prediabetes and are at high risk for developing , the American Diabetes Association reports.'Look around you. We are surrounded by [diabetes] risk,' Christine T. Tobin, president...
|
|
|
Tracking Down the Mystery of Life's 'Handedness'
NEW YORK (Logo: http://www.newscom.com/cgi-bin/prnh/20091027/NY99197LOGO) 'The molecules of life have mirror images, which can be synthesized by organic chemists, but the mirror images don't exist in life any more than a person's mirror image does,' explains...
|
|
|
Health tip: check your skin for signs of cancer
_ Health tip: check your skin for signs of cancer.
|
|
|
Nuvo Research completes redemption of 5% convertible debentures
MISSISSAUGA, ON Nuvo announced a notice of early redemption for its Debentures on February 4, 2010 'As anticipated all of these deep-in-the-money debentures were converted into common shares,' said Jim Moulds About Nuvo Research Inc.Nuvo is primarily focused...
|
|
|
Endo to Present at Barclays Capital Global Healthcare Conference
CHADDS FORD, Pa.The presentation will be webcast live and can be accessed from Endo's website at www.endo.com under the investors section. About Endo Endo Pharmaceuticals is a specialty pharmaceutical company engaged in the research, development, sale and...
|
|
|
Somanetics Reports First Quarter 2010 Results
TROY, Mich.First Quarter Highlights Somanetics Corporation (Nasdaq: SMTS) reported net revenues of $13.1 million U.S. net revenues increased 20 percent to $10.5 million First quarter income before income taxes was $3.1 million Gross margin was 87 percent...
|
|
|
Hikma 2009 Results Interviews With CEO and CFO
LONDON In a video interview on financial broadcaster http://www.cantos.com, Group CEO Said Darwazah The emerging markets-based Pharma company also reported a return to profitability in its US generics business and improving trends in its European Injectables...
|
|
|
Neovasc Presents Positive Long Term Results from Initial Clinical Study of Its Reducer(TM) Product for Refract
-- Data Presented at the American College of Cardiology 2010 Annual Meeting Suggests Treatment with the Neovasc Reducer Is Safe and Improves Angina Symptoms for at Least Three Years -- TSX Venture Exchange: NVC VANCOUVER Refractory angina is a painful and...
|
|
|
Abaxis, Inc. to Present at Sidoti & Company's Fourteenth Annual New York Emerging Growth Institutional Investo
UNION CITY, Calif.About Abaxis Abaxis develops, manufactures and markets portable blood analysis systems for use in any veterinary or human patient-care setting to provide clinicians with rapid blood constituent measurements. The system consists of a...
|
